Also trades as: AFT.NZ (NZE) · $vol 0M
AFP.AX ASX
AFT Pharmaceuticals Limited
1W: +0.3%
1M: -8.2%
3M: +14.6%
YTD: +6.8%
1Y: +43.8%
3Y: +12.0%
5Y: +52.6%
A$3.50 ($2.43)
+0.05 (+1.45%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$12M
-189.8% ▼
Capital Expenditures
$117K
+98.3% ▲
5Y CAGR: +4.7%
Free Cash Flow
-$12M
-292.0% ▼
Dividends Paid
$2M
-13.3% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
-105.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $20M | $11M | $16M | $0 | $15M |
| Depreciation & Amort. | $913K | $848K | $2M | $0 | $4M |
| Stock-Based Comp. | $13K | $0 | $139K | $0 | $0 |
| Change in Working Capital | -$5M | -$20M | -$4M | -$4M | -$34M |
| Other Non-Cash Items | -$7M | $20M | $15M | $17M | $4M |
| Operating Cash Flow | $14M | $12M | $29M | $13M | -$12M |
| — Investing Activities — | |||||
| Capital Expenditures | -$329K | -$197K | -$116K | -$281K | -$10M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$5M | -$9M | -$9M | -$7M | $0 |
| Investing Cash Flow | -$6M | -$9M | -$10M | -$7M | -$10M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1M | -$4M | -$5M | -$2M | $14M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | -$1M | -$2M | -$2M |
| Other Financing | -$3M | -$3M | -$4M | -$4M | -$1M |
| Financing Cash Flow | -$4M | -$7M | -$11M | -$7M | $11M |
| Net Change in Cash | $5M | -$5M | $9M | -$930K | -$2M |
| Cash End of Period | $8M | $3M | $12M | $11M | $10M |
| Free Cash Flow | $14M | $11M | $19M | $6M | -$12M |